Codis Continues Growth with New Senior VP of Sales and Marketing
Codis Welcomes Steven Facer as Senior VP of Sales and Marketing
In an exciting development, Codis has appointed Steven Facer as the new Senior Vice President of Sales and Marketing. Steven comes with over three decades of international pharmaceutical leadership, bringing a wealth of experience that will contribute to Codis's ambitious growth plans.
Proven Leadership Experience
Before joining Codis, Steven had a successful tenure at various prominent companies, including Thermo Fisher, Capsugel, and Catalent. His career has been marked by a proven ability to drive commercial growth, forge strategic partnerships, and expand market reach globally. At Codis, he will spearhead the sales and marketing strategy for the Haverhill facility, significantly strengthening customer partnerships.
Strengthening Codis’s Pharmaceutical Solutions
At Codis, Steven's primary focus will be to enhance the sales efforts associated with the company’s pharmaceutical solutions. His extensive experience will be crucial in navigating the complexities of the market, allowing the company to deliver innovative and effective solutions to its customers.
Steve Facer's Vision for Codis
Upon his new appointment, Steven expressed enthusiasm about joining a company poised at a pivotal moment. According to him, "Codis's commitment to quality and innovation resonates with my passion for advancing solutions that indeed benefit patients. I look forward to working with the exceptional team here to further enhance Codis's market presence and drive sustainable growth."
A Message from Codis’s CEO
Codis CEO Nicolas Fortin commented on this strategic appointment, saying, "Steve's extensive background makes him the ideal candidate to lead our Haverhill sales and marketing strategy. His commercial acumen and focus on customer relationships will be instrumental as we aim to bolster our position in the pharmaceutical sector. With strong leaders like Mark Bolling and Steven, we are well-positioned for future success."
About Codis
Codis is a global Contract Development and Manufacturing Organization (CDMO). They specialize in commercial spray drying, amorphous solid dispersions, and finished dose manufacturing catering to various sectors including pharmaceuticals and nutraceuticals. With operations across multiple locations, including over 400,000 sq ft of cGMP facilities, they combine regulatory expertise and manufacturing strength under one unified brand, enhancing their service offerings.
Frequently Asked Questions
Who is Steven Facer?
Steven Facer is the newly appointed Senior Vice President of Sales and Marketing at Codis, bringing over 30 years of experience in the pharmaceutical industry.
What is Codis's primary focus?
Codis focuses on providing advanced pharmaceutical solutions, particularly in commercial spray drying and amorphous solid dispersions.
Why is Steven Facer's appointment significant?
His extensive experience and proven leadership in driving growth and forging partnerships are expected to enhance Codis's market presence and customer relationships.
What are Codis's core sectors?
Codis serves various sectors, including pharmaceuticals, consumer health, nutraceuticals, and OTC sectors.
How does Codis ensure quality?
Codis operates under strict cGMP regulatory standards in their manufacturing facilities to ensure high-quality products and services.
About The Author
Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.